147 filings
Page 6 of 8
8-K
i1xz9
19 Apr 16
OncoSec Presents Positive Melanoma Clinical Data at American Association for Cancer Research (AACR) Annual Meeting 2016
12:00am
8-K
2jezniuctg61hn3c
15 Apr 16
OncoSec Announces New Senior Leadership Responsibilities
12:00am
8-K
m53n 0d3kth0o
8 Mar 16
OncoSec Announces Second Quarter and YTD Results for Fiscal Year 2016 and Calendar 2016 Milestones
12:00am
8-K
w2qrew
26 Jan 16
Termination of a Material Definitive Agreement
12:00am
8-K
whspn78ap5s9
29 Dec 15
Departure of Directors or Certain Officers
12:00am
8-K
9gpdmp1hm16pc
9 Dec 15
OncoSec Announces First Quarter Results for Fiscal Year End 2016
12:00am
8-K
gtgrozr2f9y2p55
7 Dec 15
Submission of Matters to a Vote of Security Holders
12:00am
8-K
7dvj5ch s14y
5 Nov 15
Entry into a Material Definitive Agreement
12:00am
8-K
joj3f9ceglj2 6ic
30 Oct 15
Entry into a Material Definitive Agreement
12:00am
8-K
pazud49l88t z9
30 Oct 15
Entry into a Material Definitive Agreement
12:00am
8-K
u0tra 80i09tmha1
15 Oct 15
OncoSec Announces Fourth Quarter and YTD Results for Fiscal Year End 2015
12:00am
8-K
9ap1cggigdyr62ia61gz
5 Oct 15
Other Events
12:00am
8-K
ftvivizo q71vt6z
5 Aug 15
Submission of Matters to a Vote of Security Holders
12:00am
8-K
59xzni ql8rcyzdh6gkb
25 Jun 15
OncoSec Medical Appoints Richard B. Slansky as Chief Financial Officer
12:00am
8-K
v1t2r 43ts74d527nf
9 Jun 15
Results of Operations and Financial Condition
12:00am
8-K
kvtv35iyvr661c22ap5
4 Jun 15
Entry into a Material Definitive Agreement
12:00am
8-K
5bx7zgnkpln0k2vv9
15 May 15
OncoSec Medical Announces Reverse Stock Split in Preparation for Proposed Uplisting to NASDAQ Capital Market
12:00am
8-K
22x9d1fykitme6sz
12 Mar 15
OncoSec Medical Announces Six Months Results for Fiscal Year End 2015
12:00am
8-K
9879skwu
11 Mar 15
Entry into a Material Definitive Agreement
12:00am
8-K
8jwslpwincd
2 Jan 15
Entry into a Material Definitive Agreement
12:00am